Improved Signs, Symptoms, and Quality of Life Associated With Dry Eye Syndrome: Hydroxypropyl Cellulose Ophthalmic Insert Patient Registry

@article{Koffler2010ImprovedSS,
  title={Improved Signs, Symptoms, and Quality of Life Associated With Dry Eye Syndrome: Hydroxypropyl Cellulose Ophthalmic Insert Patient Registry},
  author={B. Koffler and M. Mcdonald and Donald S. Nelinson},
  journal={Eye & Contact Lens: Science & Clinical Practice},
  year={2010},
  volume={36},
  pages={170-176}
}
  • B. Koffler, M. Mcdonald, Donald S. Nelinson
  • Published 2010
  • Medicine
  • Eye & Contact Lens: Science & Clinical Practice
    • Objectives: To evaluate the acceptability, ease of use, and efficacy of hydroxypropyl cellulose ophthalmic inserts in reducing signs and symptoms of moderate-to-severe dry eye syndrome (DES), and improving quality of life (QoL) and activities of daily living (ADL). Methods: The multicenter, prospective, open-label, 4-week registry comprised 520 patients with bilateral DES and a history of artificial tear use, or a desire to use artificial tears within the previous week. Visit 1 encompassed a… CONTINUE READING
    View on Wolters Kluwer
    ncbi.nlm.nih.gov
    23 Citations
    Highly Influencial Citations
    1
    Background Citations
    3
    Methods Citations
    3
    23 Citations
    Citation Type

    Citation Type

    Correlating Patient-Reported Response to Hydroxypropyl Cellulose Ophthalmic Insert (LACRISERT®) Therapy with Clinical Outcomes: Tools for Predicting Response
    • 11
    Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye
    • 22
    • PDF
    Long-Term Use of Hydroxypropyl Cellulose Ophthalmic Insert to Relieve Symptoms of Dry Eye in a Contact Lens Wearer: Case-Based Experience
    • 19
    Impact of Dry Eye Syndrome on Vision-Related Quality of Life in a Non-Clinic-Based General Population
    • 76
    • PDF
    Current and emerging therapy of dry eye disease. Part A: pharmacological modalities
    • 1
    Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies.
    • 72
    Dysfunctional tear syndrome: dry eye disease and associated tear film disorders – new strategies for diagnosis and treatment
    • 76
    • PDF
    Current and emerging therapy of dry eye disease. Part B: non-pharmacological modalities
    Correlation Analysis of Ocular Symptoms and Signs in Patients with Dry Eye
    • 8
    • PDF
    Validation of measurement scales in ocular graft-versus-host disease.
    • 70

    References

    SHOWING 1-10 OF 22 REFERENCES
    Extending the duration of tear film protection in dry eye syndrome: review and retrospective case series study of the hydroxypropyl cellulose ophthalmic insert.
    • 20
    The Lack of Association Between Signs and Symptoms in Patients With Dry Eye Disease
    • 575
    Impact of dry eye syndrome on vision-related quality of life.
    • 593
    Reliability and validity of the Ocular Surface Disease Index.
    • 1,613
    • PDF
    Current patterns in the use of diagnostic tests in dry eye evaluation.
    • 126
    Dry eye in diabetic patients.
    • 151
    Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis.
    • J. Hill
    • Medicine
    • The British journal of ophthalmology
    • 1989
    • 20
    • PDF
    Advances in understanding and managing dry eye disease.
    • M. Lemp
    • Medicine
    • American journal of ophthalmology
    • 2008
    • 231
    • PDF
    Prevalence, risk, and risk factors for oral and ocular dryness with particular emphasis on rheumatoid arthritis.
    • 31
    Dry eye diagnosis.
    • 142
    • PDF